Try our mobile app

Published: 2022-04-28 07:45:16 ET
<<<  go to CTS company page
EX-99.1 2 cts-ex991_6.htm EX-99.1 cts-ex991_6.htm

 

Exhibit 99.1

 

 

 

April 28, 2022  

FOR IMMEDIATE RELEASE

 

 

CTS Announces First Quarter 2022 Results

Delivered solid growth, further advancing diversification strategy

 

Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “sense, connect and move” today announced first quarter 2022 results.

 

“Our solid first quarter results highlight the progress of our diversification strategy and our ability to deliver enhanced profitability, with revenue growing 15% and Adjusted EBITDA margin expanding 350-basis points. Our acquisition of TEWA Sensors in the first quarter and our recently announced agreement to acquire Ferroperm demonstrate our efforts to expand growth of non-transportation end markets and will move this portion of the business closer to 50% of total revenues in the year ahead,” said Kieran O’Sullivan, CEO of CTS Corporation. "Demand remains robust across all end markets. Our strong balance sheet and solid cash flow generation continue to be key competitive advantages as we further execute on our strategic priorities and drive value for our shareholders.”

 

First Quarter 2022 Results

 

Sales were $147.7 million, up 15% year-over-year. Sales to non-transportation end markets increased 30%, and sales to the transportation end market increased 4% over the same period.

Net income was $20.2 million, or $0.63 per diluted share, compared to $12.0 million, or $0.37 per diluted share, in the first quarter of 2021.

Adjusted diluted EPS was $0.67, up from $0.46 in the first quarter of 2021.

Adjusted EBITDA margin was 23.5% compared to 20.0% in the first quarter of 2021.

Operating cash flow was $19.3 million compared to $20.1 million in the first quarter of 2021.

 

2022 Guidance

 

Including the impact of the recent TEWA Sensors acquisition, CTS now expects full year 2022 sales to be in the range of $550 – $580 million, up from the previous guidance of $525 – $550 million and adjusted diluted EPS in the range of $2.20 - $2.45, up from the previous guidance of $2.00 – $2.25. Management continues to carefully evaluate the impact of inflation, supply chain issues, COVID 19-related disruptions in China, and geopolitical risks.

 

Conference Call and Supplemental Materials

 

As previously announced, the Company has scheduled a conference call at 10:00 a.m. (EDT) today to discuss the first quarter 2022 financial results. The dial-in number for the U.S. and Canada is 844-200-6205 (+1 929-526-1599, if calling from outside the U.S. or Canada).  The passcode is 549088. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://www.ctscorp.com/investors/events-presentations/.

 

 

 

 

 

 

www.ctscorp.com

 


 

Exhibit 99.1

 

About CTS

 

CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move.  The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

 

Safe Harbor

 

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management’s expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause CTS’ actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: the ultimate impact of the COVID-19 pandemic on CTS’ business, results of operations or financial condition; changes in the economy generally and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions including TEWA Temperature Sensors and Ferroperm Piezoceramics (once closed subject to obtaining regulatory approvals and satisfaction of customary closing conditions); the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; and risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact the conflict between Russia and Ukraine may have on our business, results of operations and financial condition). Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

 

Non-GAAP Financial Measures

 

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS’ management believes that non-GAAP financial measures can be useful to investors in analyzing CTS’ financial performance and results of operations over time. CTS recommends that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.

 

The information included in this press release includes the non-GAAP financial measures of adjusted gross margin, adjusted operating earnings, adjusted EBITDA, adjusted net earnings, adjusted diluted earnings per share, debt to capitalization ratio, controllable working capital ratio, and free cash flow. Many of these non-GAAP financial measures exclude the effect of certain expenses and income not related directly to the underlying performance of CTS’ fundamental business operations.

 

CTS believes that adjusted gross margins, adjusted operating earnings, adjusted EBITDA, adjusted net earnings and, adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations or were not part of CTS’ business operations during a comparable period.

www.ctscorp.com

 


 

Exhibit 99.1

 

CTS believes that debt to capitalization ratio is a measurement of financial leverage and provides an insight into the financial structure of CTS and its financial strength. CTS believes the controllable working capital ratio provides an objective measure of the efficiency with which CTS manages its short-term capital needs.  CTS believes that free cash flow is a useful measure of its ability to generate cash.

 

CTS believes that these non-GAAP financial measures are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. Note that CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies.

 

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

 

Contact

 

Ashish Agrawal

Vice President and Chief Financial Officer

CTS Corporation

4925 Indiana Avenue

Lisle, IL 60532 USA

+1 (630) 577-8800

ashish.agrawal@ctscorp.com


www.ctscorp.com

 


 

Exhibit 99.1

 

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED

(In thousands of dollars, except per share amounts)

 

 

 

 

Three Months Ended

 

 

 

March 31,

2022

 

 

March 31,

2021

 

Net sales

 

$

147,695

 

 

$

128,427

 

Cost of goods sold

 

 

93,355

 

 

 

85,836

 

Gross margin

 

 

54,340

 

 

 

42,591

 

Selling, general and administrative expenses

 

 

21,788

 

 

 

18,325

 

Research and development expenses

 

 

6,194

 

 

 

5,687

 

Restructuring charges

 

 

312

 

 

 

81

 

Operating earnings

 

 

26,046

 

 

 

18,498

 

Other (expense) income:

 

 

 

 

 

 

 

 

Interest expense

 

 

(546

)

 

 

(555

)

Interest income

 

 

180

 

 

 

202

 

Other income (expense), net

 

 

66

 

 

 

(3,356

)

Total other expense, net

 

 

(300

)

 

 

(3,709

)

Earnings before income taxes

 

 

25,746

 

 

 

14,789

 

Income tax expense

 

 

5,507

 

 

 

2,799

 

Net earnings

 

 

20,239

 

 

 

11,990

 

Earnings per share:

 

 

 

 

 

 

 

 

Basic

 

$

0.63

 

 

$

0.37

 

Diluted

 

$

0.63

 

 

$

0.37

 

Basic weighted – average common shares outstanding:

 

 

32,123

 

 

 

32,319

 

Effect of dilutive securities

 

 

204

 

 

 

301

 

Diluted weighted – average common shares outstanding:

 

 

32,327

 

 

 

32,620

 

Cash dividends declared per share

 

$

0.04

 

 

$

0.04

 

 

 

 

 

 

www.ctscorp.com

 


 

Exhibit 99.1

 

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

 

 

 

(Unaudited)

 

 

 

 

 

 

 

March 31, 2022

 

 

December 31, 2021

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

126,118

 

 

$

141,465

 

Accounts receivable, net

 

 

95,107

 

 

 

82,191

 

Inventories, net

 

 

52,454

 

 

 

49,506

 

Other current assets

 

 

18,366

 

 

 

15,927

 

Total current assets

 

 

292,045

 

 

 

289,089

 

Property, plant and equipment, net

 

 

97,041

 

 

 

96,876

 

Operating lease assets, net

 

 

23,212

 

 

 

21,594

 

Other Assets

 

 

 

 

 

 

 

 

Prepaid pension asset

 

 

31,882

 

 

 

49,382

 

Goodwill

 

 

117,524

 

 

 

109,798

 

Other intangible assets, net

 

 

79,849

 

 

 

69,888

 

Deferred income taxes

 

 

23,828

 

 

 

25,415

 

Other

 

 

19,365

 

 

 

2,420

 

Total other assets

 

 

272,448

 

 

 

256,903

 

Total Assets

 

$

684,746

 

 

$

664,462

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

60,010

 

 

$

55,537

 

Operating lease obligations

 

 

3,522

 

 

 

3,393

 

Accrued payroll and benefits

 

 

12,954

 

 

 

18,418

 

Accrued expenses and other liabilities

 

 

38,554

 

 

 

36,718

 

Total current liabilities

 

 

115,040

 

 

 

114,066

 

Long-term debt

 

 

50,000

 

 

 

50,000

 

Long-term operating lease obligations

 

 

22,712

 

 

 

21,354

 

Long-term pension obligations

 

 

6,464

 

 

 

6,886

 

Deferred income taxes

 

 

5,865

 

 

 

5,894

 

Other long-term obligations

 

 

4,487

 

 

 

2,684

 

Total Liabilities

 

 

204,568

 

 

 

200,884

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

 

 

 

Common stock

 

 

316,496

 

 

 

314,620

 

Additional contributed capital

 

 

41,158

 

 

 

42,549

 

Retained earnings

 

 

511,197

 

 

 

492,242

 

Accumulated other comprehensive loss

 

 

(3,445

)

 

 

(4,525

)

Total shareholders’ equity before treasury stock

 

 

865,406

 

 

 

844,886

 

Treasury stock

 

 

(385,228

)

 

 

(381,308

)

Total shareholders’ equity

 

 

480,178

 

 

 

463,578

 

Total Liabilities and Shareholders’ Equity

 

$

684,746

 

 

$

664,462

 

www.ctscorp.com

 


 

Exhibit 99.1

 

CTS CORPORATION AND SUBSIDIARIES

OTHER SUPPLEMENTAL INFORMATION - UNAUDITED

(In millions of dollars, except per share amounts)

 

Adjusted Gross Margin

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Gross margin

 

$

54.3

 

 

$

42.6

 

 

$

184.6

 

 

$

139.1

 

 

$

157.6

 

Adjustments to reported gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory fair value step-up

 

$

0.6

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted gross margin

 

$

54.9

 

 

$

42.6

 

 

$

184.6

 

 

$

139.1

 

 

$

157.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

147.7

 

 

$

128.4

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted gross margin as a % of net sales

 

 

37.2

%

 

 

33.2

%

 

 

36.0

%

 

 

32.8

%

 

 

33.6

%

 

Adjusted Operating Earnings

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Operating earnings

 

$

26.0

 

 

$

18.5

 

 

$

76.5

 

 

$

45.1

 

 

$

53.8

 

Adjustments to reported operating earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.3

 

 

 

0.1

 

 

 

1.7

 

 

 

1.8

 

 

 

7.4

 

Environmental charges

 

 

0.5

 

 

 

0.2

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

0.5

 

 

 

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Inventory fair value step-up

 

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Total adjustments to reported operating earnings

 

$

1.9

 

 

$

0.3

 

 

$

3.9

 

 

$

4.9

 

 

$

10.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating earnings

 

$

28.0

 

 

$

18.8

 

 

$

80.4

 

 

$

50.0

 

 

$

63.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

147.7

 

 

$

128.4

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating earnings as a % of net sales

 

 

19.0

%

 

 

14.6

%

 

 

15.7

%

 

 

11.8

%

 

 

13.6

%

www.ctscorp.com

 


 

Exhibit 99.1

 

 

Adjusted EBITDA

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Net earnings (loss)

 

$

20.2

 

 

$

12.0

 

 

$

(41.9

)

 

$

34.7

 

 

$

36.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense

 

 

6.7

 

 

 

6.8

 

 

 

26.9

 

 

 

26.7

 

 

 

24.6

 

Interest expense

 

 

0.5

 

 

 

0.6

 

 

 

2.1

 

 

 

3.3

 

 

 

2.6

 

Tax expense (benefit)

 

 

5.5

 

 

 

2.8

 

 

 

(19.0

)

 

 

10.8

 

 

 

14.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

 

33.0

 

 

 

22.2

 

 

 

(31.8

)

 

 

75.4

 

 

 

77.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments to EBITDA:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.3

 

 

 

0.1

 

 

 

1.7

 

 

 

1.8

 

 

 

6.9

 

Environmental charges

 

 

0.5

 

 

 

0.2

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

0.5

 

 

 

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Inventory fair value step-up

 

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Non-cash pension expense

 

 

 

 

 

1.9

 

 

 

132.4

 

 

 

2.5

 

 

 

0.8

 

Foreign currency (gain) loss

 

 

(0.3

)

 

 

1.3

 

 

 

3.3

 

 

 

(5.3

)

 

 

1.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total adjustments to EBITDA

 

 

1.7

 

 

 

3.5

 

 

 

139.7

 

 

 

2.1

 

 

 

12.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

34.7

 

 

$

25.7

 

 

$

107.8

 

 

$

77.5

 

 

$

89.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

147.7

 

 

$

128.4

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA as a % of net sales

 

 

23.5

%

 

 

20.0

%

 

 

21.0

%

 

 

18.3

%

 

 

19.1

%

www.ctscorp.com

 


 

Exhibit 99.1

 

Adjusted Net Earnings

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Net earnings (loss) (A)

 

$

20.2

 

 

$

12.0

 

 

$

(41.9

)

 

$

34.7

 

 

$

36.1

 

Adjustments to reported net earnings (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.3

 

 

 

0.1

 

 

 

1.7

 

 

 

1.8

 

 

 

7.4

 

Environmental charges

 

 

0.5

 

 

 

0.2

 

 

 

2.3

 

 

 

2.8

 

 

 

2.3

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.5

)

Transaction costs

 

 

0.5

 

 

 

 

 

 

 

 

 

0.3

 

 

 

0.7

 

Inventory fair value step-up

 

 

0.6

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of tax improvement initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.1

 

Non-cash pension expense

 

 

 

 

 

1.9

 

 

 

132.4

 

 

 

2.5

 

 

 

0.8

 

Foreign currency (gain) loss

 

 

(0.3

)

 

 

1.3

 

 

 

3.3

 

 

 

(5.3

)

 

 

1.8

 

Total adjustments to reported net earnings (loss)

 

$

1.7

 

 

$

3.5

 

 

$

139.7

 

 

$

2.1

 

 

$

12.6

 

Total adjustments, tax affected (B)

 

$

1.4

 

 

$

3.0

 

 

$

108.6

 

 

$

0.4

 

 

$

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase in valuation allowances

 

 

 

 

 

 

 

 

0.9

 

 

 

0.2

 

 

 

 

Other discrete tax items

 

 

 

 

 

 

 

 

(4.7

)

 

 

1.2

 

 

 

1.8

 

Total tax adjustments (C)

 

$

 

 

$

 

 

$

(3.8

)

 

$

1.4

 

 

$

1.8

 

Adjusted net earnings (A+B+C)

 

$

21.7

 

 

$

15.0

 

 

$

63.0

 

 

$

36.5

 

 

$

48.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

147.7

 

 

$

128.4

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net earnings as a % of net sales

 

 

14.7

%

 

 

11.7

%

 

 

12.3

%

 

 

8.6

%

 

 

10.3

%

 

Adjusted Diluted Earnings Per Share

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

GAAP diluted earnings (loss) per share

 

$

0.63

 

 

$

0.37

 

 

$

(1.30

)

 

$

1.06

 

 

$

1.09

 

Tax affected charges to reported diluted earnings (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges

 

 

0.01

 

 

 

 

 

 

0.06

 

 

 

0.04

 

 

 

0.18

 

Foreign currency (gain) loss

 

 

(0.01

)

 

 

0.04

 

 

 

0.10

 

 

 

(0.16

)

 

 

0.05

 

Non-cash pension expense

 

 

 

 

 

0.04

 

 

 

3.13

 

 

 

0.06

 

 

 

0.02

 

Environmental charges

 

 

0.01

 

 

 

0.01

 

 

 

0.05

 

 

 

0.07

 

 

 

0.05

 

Transaction costs

 

 

0.02

 

 

 

 

 

 

 

 

 

0.01

 

 

 

0.02

 

Inventory fair value step-up

 

 

0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

Legal settlement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.01

)

Discrete tax items

 

 

 

 

 

 

 

 

(0.11

)

 

 

0.04

 

 

 

0.05

 

Adjusted diluted earnings per share

 

$

0.67

 

 

$

0.46

 

 

$

1.93

 

 

$

1.12

 

 

$

1.45

 

www.ctscorp.com

 


 

Exhibit 99.1

 

 

Debt to Capitalization

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Total debt (A)

$

50.0

 

 

$

50.0

 

 

$

50.0

 

 

$

54.6

 

 

$

99.7

 

Total shareholders' equity (B)

$

480.2

 

 

$

435.7

 

 

$

463.6

 

 

$

423.7

 

 

$

405.2

 

Total capitalization (A+B)

$

530.2

 

 

$

485.7

 

 

$

513.6

 

 

$

478.3

 

 

$

504.9

 

Total debt to capitalization

 

9.4

%

 

 

10.3

%

 

 

9.7

%

 

 

11.4

%

 

 

19.7

%

Controllable Working Capital

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

2022

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Net accounts receivable

$

95.1

 

$

81.6

 

 

$

82.2

 

 

$

81.0

 

 

$

78.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net inventory

$

52.5

 

$

47.5

 

 

$

49.5

 

 

$

45.9

 

 

$

42.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

$

(60.0

)

$

(53.3

)

 

$

(55.5

)

 

$

(50.5

)

 

$

(48.2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Controllable working capital

$

87.6

 

$

75.8

 

 

$

76.2

 

 

$

76.4

 

 

$

72.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter sales

$

147.7

 

$

128.4

 

 

$

132.5

 

 

$

123.0

 

 

$

115.0

 

Multiplied by 4

 

4

 

 

4

 

 

 

4

 

 

 

4

 

 

 

4

 

Annualized sales

$

590.8

 

$

513.6

 

 

$

530.1

 

 

$

492.1

 

 

$

460.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Controllable working capital as a % of annualized net sales

 

14.8

%

 

14.8

%

 

 

14.4

%

 

 

15.5

%

 

 

15.7

%

 

Free Cash Flow

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Net cash provided by operating activities

 

$

19.3

 

 

$

20.1

 

 

$

86.1

 

 

$

76.8

 

 

$

64.4

 

Capital expenditures

 

 

(3.4

)

 

 

(1.6

)

 

 

(15.6

)

 

 

(14.9

)

 

 

(21.7

)

Free cash flow

 

$

15.9

 

 

$

18.5

 

 

$

70.5

 

 

$

61.9

 

 

$

42.7

 

 

Capital Expenditures

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Capital expenditures

 

$

3.4

 

 

$

1.6

 

 

$

15.6

 

 

$

14.9

 

 

$

21.7

 

Net sales

 

$

147.7

 

 

$

128.4

 

 

$

512.9

 

 

$

424.1

 

 

$

469.0

 

Capex as % of net sales

 

 

2.3

%

 

 

1.3

%

 

 

3.0

%

 

 

3.5

%

 

 

4.6

%

www.ctscorp.com

 


 

Exhibit 99.1

 

 

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

 

 

 

Three Months Ended

March 31,

 

 

Twelve Months Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2020

 

 

2019

 

Depreciation and amortization expense

 

$

6.7

 

 

$

6.8

 

 

$

26.9

 

 

$

26.7

 

 

$

24.6

 

Stock-based compensation expense

 

$

2.0

 

 

$

1.2

 

 

$

6.1

 

 

$

3.4

 

 

$

5.0

 

 

www.ctscorp.com